The $10-50 price range often includes mid-sized businesses with proven track records and plenty of growth runway ahead. They also usually carry less risk than penny stocks, though they’re not immune to volatility as many lack the scale advantages of their larger peers.
This is precisely where StockStory comes in - we do the heavy lifting to identify companies with solid fundamentals so you can invest with confidence. That said, here are three stocks under $50 to avoid and some other investments you should consider instead.
Nature's Sunshine (NATR)
Share Price: $15.45
Started on a kitchen table in Utah, Nature’s Sunshine (NASDAQ: NATR) manufactures and sells nutritional and personal care products.
Why Does NATR Fall Short?
- Annual revenue growth of 4.4% over the last three years was below our standards for the consumer staples sector
- Modest revenue base of $492 million gives it less fixed cost leverage and fewer distribution channels than larger companies
- Estimated sales growth of 2.8% for the next 12 months implies demand will slow from its three-year trend
Nature's Sunshine’s stock price of $15.45 implies a valuation ratio of 14.4x forward P/E. If you’re considering NATR for your portfolio, see our FREE research report to learn more.
Baxter (BAX)
Share Price: $27.07
With a history dating back to 1931 and products used in over 100 countries, Baxter International (NYSE: BAX) provides essential healthcare products including dialysis therapies, IV solutions, infusion systems, surgical products, and patient monitoring technologies to hospitals and clinics worldwide.
Why Are We Out on BAX?
- Underwhelming constant currency revenue performance over the past two years suggests its product offering at current prices doesn’t resonate with customers
- Sales were less profitable over the last five years as its earnings per share fell by 8.5% annually, worse than its revenue declines
- Negative returns on capital show that some of its growth strategies have backfired
At $27.07 per share, Baxter trades at 12.8x forward P/E. Check out our free in-depth research report to learn more about why BAX doesn’t pass our bar.
Simmons First National (SFNC)
Share Price: $23.95
With roots dating back to 1903 and a presence across Arkansas, Kansas, Missouri, Oklahoma, Tennessee, and Texas, Simmons First National (NASDAQ: SFNC) is a regional bank holding company that provides banking and financial services to individuals and businesses.
Why Do We Pass on SFNC?
- Muted 5.4% annual net interest income growth over the last five years shows its demand lagged behind its banking peers
- Efficiency ratio is expected to worsen by 18.7 percentage points over the next year
- Performance over the past five years shows its incremental sales were much less profitable, as its earnings per share fell by 4.5% annually
Simmons First National is trading at $23.95 per share, or 1x forward P/B. To fully understand why you should be careful with SFNC, check out our full research report (it’s free).
High-Quality Stocks for All Market Conditions
WHILE YOU’RE HERE: Top 9 Market-Beating Stocks. The best stocks don’t just beat the market once. They do it again. And again. Robust revenue growth, rising free cash flow, returns on capital that leave their competition in the dust. The market has already rewarded these businesses.
But our AI platform says the party isn’t over. Find out which 9 stocks made the cut this week — FREE. Get Our Top 9 Market-Beating Stocks for Free HERE.
Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,460% between June 2020 and June 2025) as well as under-the-radar businesses like the once-small-cap company Comfort Systems (+1,154% between June 2020 and June 2025). Find your next big winner with StockStory today.
